Brand profile · Biotechnology Research

SpeeDx Pty Ltd

SpeeDx Pty Ltd works in Biotechnology Research, out of Eveleigh, New South Wales. Ownership is privately held; it publishes at plexpcr.com. The record carries three addresses across three office countries. The record counts 83 people. Tagged sexual health and biotechnology. Two Australian registrations (ABN) are candidate matches. The latest round on record is Series unknown at US$26.0M. The record links nine similar brands, most of them in Biotechnology Research.

Profile live Privately Held Founded 2009 2 registry matches ABN 3 office countries US$ 26.0M Series unknown
Registry match · ABR

Key facts

Counted staff
83
self-reported 51–200 band
Founded
2009
17 years
Registry matches
2
ABR
Office countries
3
3 addresses
Funding rounds
5
Series unknown · Mar 2023 · US$ 26.0M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entities

1 brand → 2 possible registrationsThese are name matches on ABR. 2 registrations share this brand's name; which one you contract with is a question for the register.
  • SPEEDX PTY LTD

    ABN46135095886

    NSWMedium confidenceMatched on exact nameABR

  • SPEEDX AUSTRALIA PTY LIMITED

    ABN54683554181

    NSWMedium confidenceMatched on exact nameABR

Legal entities

SpeeDx Pty Ltd: 2 registry entitiesSpeeDx Pty Ltd is linked to 2 registry entities: SPEEDX PTY LTD (ABN 46135095886, candidate); SPEEDX AUSTRALIA PTY LIMITED (ABN 54683554181, candidate).SpeeDx Pty LtdSPEEDX PTY LTDABN 46135095886Candidate · Medium confidenceSPEEDX AUSTRALIA PTYLIMITEDABN 54683554181Candidate · Medium confidence
Show as table · SpeeDx Pty Ltd: 2 registry entities
SpeeDx Pty Ltd: 2 registry entities
SPEEDX PTY LTDABN 46135095886
SPEEDX AUSTRALIA PTY LIMITEDABN 54683554181
Confirmed matches0 of 2

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.

Specialties

All 13 specialties
  • PCR
  • qPCR
  • Multiplex
  • Molecular Diagnostics
  • Clinical Diagnostics
  • Biotechnology
  • IVD
  • PlexZyme
  • STI
  • STD
  • Antibiotic Resistance
  • Antimicrobial Stewardship
  • Sexual Health

Locations

3
Countries with an office address3 addresses on record
AustraliaprimaryUnited KingdomUnited States

Country footprint

Offices in 3 countriesCountry footprint: 3 countries, primary AU. Codes: AU, GB, US.3 countriesprimary AUAUGBUS
Show as table · Offices in 3 countries
Offices in 3 countries
Countries3
Primary countryAU

All codes: AU GB US

Addresses

  • AUSuite G16, National Innovation Centre, Australian Technology Park, 4 Cornwallis Street; Eveleigh, New South Wales 2015Primary
  • US1601 Trinity St; Austin, Texas 78712
  • GBKemp House; 152-160 City Road; London, United Kingdom EC1V 2NX

Grid intelligence Members

Funding

Last round · 28 March 2023US$ 26.0MSeries unknown
Rounds5
Round typeSeries unknown · venture round
Amount (USD)26,000,000
Stage ranknot recorded
Investors named0
Since last round2 yr 9 mo

Funding

5 funding roundsFunding timeline. Latest round 28 Mar 2023: Series unknown, US$ 26.0M.20092026Series unknownUS$ 26.0M5 rounds
Show as table · 5 funding rounds
5 funding rounds
Rounds5
Axis2009 to 2026
Series unknown · 28 Mar 2023US$ 26.0M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entities operate under SpeeDx Pty Ltd?

Two New South Wales entities on the ABR. SPEEDX PTY LTD (ABN 46 135 095 886) and SPEEDX AUSTRALIA PTY LIMITED (ABN 54 683 554 181). Both medium confidence.

How many people work at SpeeDx Pty Ltd?

The record holds 83 counted staff profiles at January 2026, inside the self-reported 51–200 band.

Where does SpeeDx Pty Ltd have offices?

Three addresses on record across 3 countries. Primary: Suite G16, National Innovation Centre, Australian Technology Park, 4 Cornwallis Street, Eveleigh, New South Wales 2015.

Has SpeeDx Pty Ltd raised funding?

Five rounds. Latest 28 March 2023: Series unknown, US$26,000,000.

What does SpeeDx Pty Ltd list as its specialties?

13 tags on the brand's own list, among them sexual health and biotechnology.

Which companies are listed alongside SpeeDx Pty Ltd?

21 profiles list SpeeDx Pty Ltd as a peer — 94th percentile in Biotechnology Research. It lists ten peers of its own. Inventia Life Science and Genetic Signatures list it back.

What is SpeeDx Pty Ltd's website?